Human endothelial cell activation by Escherichia coli and staphylococcus aureus is mediated by TNF and IL-1β secondarily to activation of C5 and CD14 in whole blood

Journal of Immunology

Volumn 196, Issue 5, 2016, Pages 2293-2299

  Nymo, Stig ^a,b,c,d   Gustavsen, Alice ^c,d   Nilsson, Per H ^c,d   Lau, Corinna ^a,b   Espevik, Terje ^e   Mollnes, Tom Eirik ^a,b,c,d,e  

^a NORDLAND HOSPITAL   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY OF OSLO   (Norway)

^e NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CANAKINUMAB; CD14 ANTIGEN; COMPLEMENT COMPONENT C5; ECULIZUMAB; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ERITORAN; INFLIXIMAB; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR; BIOLOGICAL MARKER; CYTOKINE; PROTEIN MD 2;

ARTICLE; BLOOD; CELL ACTIVATION; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; ESCHERICHIA COLI; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INCUBATION TIME; PATTERN RECOGNITION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; SERUM; STAPHYLOCOCCUS AUREUS; ANTAGONISTS AND INHIBITORS; CELL CULTURE; COMPLEMENT ACTIVATION; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; UMBILICAL VEIN ENDOTHELIAL CELL;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD14; BIOMARKERS; CELLS, CULTURED; COMPLEMENT ACTIVATION; COMPLEMENT C5; CYTOKINES; ENDOTHELIAL CELLS; ESCHERICHIA COLI; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERLEUKIN-1BETA; LYMPHOCYTE ANTIGEN 96; STAPHYLOCOCCUS AUREUS; TUMOR NECROSIS FACTORS;

EID: 84962030266     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1502220     Document Type: Article

References (43)

1. Martin, G. S., D. M. Mannino, S. Eaton, and M. Moss. 2003. The epidemiology of sepsis in the United States from 1979 through 2000. N. Engl. J. Med. 348: 1546-1554
2. Mai, J., A. Virtue, J. Shen, H. Wang, and X.-F. Yang. 2013. An evolving new paradigm: endothelial cells-conditional innate immune cells. J. Hematol. Oncol. 6: 61
3. Harding, M., and P. Kubes. 2012. Innate immunity in the vasculature: interactions with pathogenic bacteria. Curr. Opin. Microbiol. 15: 85-91
4. van Hinsbergh, V. W. M. 2012. Endothelium-role in regulation of coagulation and inflammation. Semin. Immunopathol. 34: 93-106
5. Zhao, H., A. R. Anand, and R. K. Ganju. 2014. Slit2-Robo4 pathway modulates lipopolysaccharide-induced endothelial inflammation and its expression is dysregulated during endotoxemia. J. Immunol. 192: 385-393
6. London, N. R., W. Zhu, F. A. Bozza, M. C. Smith, D. M. Greif, L. K. Sorensen, L. Chen, Y. Kaminoh, A. C. Chan, S. F. Passi, C. W. Day, et al. 2010. Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci. Transl. Med. 2: 23ra19
7. Jones, C. A., N. R. London, H. Chen, K. W. Park, D. Sauvaget, R. A. Stockton, J. D. Wythe, W. Suh, F. Larrieu-Lahargue, Y.-S. Mukouyama, et al. 2008. Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat. Med. 14: 448-453
8. Nymo, S., N. Niyonzima, T. Espevik, and T. E. Mollnes. 2014. Cholesterol crystal-induced endothelial cell activation is complement-dependent and mediated by TNF. Immunobiology 219: 786-792
9. Kumar, H., T. Kawai, and S. Akira. 2009. Toll-like receptors and innate immunity. Biochem. Biophys. Res. Commun. 388: 621-625
10. Di Gioia, M., and I. Zanoni. 2015. Toll-like receptor co-receptors as master regulators of the immune response. Mol. Immunol. 63: 143-152
11. Kolev, M., G. Le Friec, and C. Kemper. 2014. Complement-tapping into new sites and effector systems. Nat. Rev. Immunol. 14: 811-820
12. Holers, V. M. 2014. Complement and its receptors: new insights into human disease. Annu. Rev. Immunol. 32: 433-459
13. Mollnes, T. E., W.-C. Song, and J. D. Lambris. 2002. Complement in inflammatory tissue damage and disease. Trends Immunol. 23: 61-64
14. Skjeflo, E. W., D. Christiansen, T. Espevik, E. W. Nielsen, and T. E. Mollnes. 2014. Combined inhibition of complement and CD14 efficiently attenuated the inflammatory response induced by Staphylococcus aureus in a human whole blood model. J. Immunol. 192: 2857-2864
15. Lappegård, K. T., D. Christiansen, A. Pharo, E. B. Thorgersen, B. C. Hellerud, J. Lindstad, E. W. Nielsen, G. Bergseth, D. Fadnes, T. G. Abrahamsen, et al. 2009. Human genetic deficiencies reveal the roles of complement in the inflammatory network: lessons from nature. Proc. Natl. Acad. Sci. USA 106: 15861-15866
16. Brekke, O.-L., D. Christiansen, H. Fure, A. Pharo, M. Fung, J. Riesenfeld, and T. E. Mollnes. 2008. Combined inhibition of complement and CD14 abolish E. coli-induced cytokine-, chemokine- and growth factor-synthesis in human whole blood. Mol. Immunol. 45: 3804-3813
17. Huber-Lang, M., A. Barratt-Due, S. E. Pischke, Ø. Sandanger, P. H. Nilsson, M. A. Nunn, S. Denk, W. Gaus, T. Espevik, and T. E. Mollnes. 2014. Double blockade of CD14 and complement C5 abolishes the cytokine storm and improves morbidity and survival in polymicrobial sepsis in mice. J. Immunol. 192: 5324-5331
18. Lau, C., K. S. Gunnarsen, L. S. Høydahl, J. T. Andersen, G. Berntzen, A. Pharo, J. K. Lindstad, J. K. Ludviksen, O.-L. Brekke, A. Barratt-Due, et al. 2013. Chimeric anti-CD14 IGG2/4 hybrid antibodies for therapeutic intervention in pig and human models of inflammation. J. Immunol. 191: 4769-4777
19. Finch, A. M., A. K. Wong, N. J. Paczkowski, S. K. Wadi, D. J. Craik, D. P. Fairlie, and S. M. Taylor. 1999. Low-molecular-weight peptidic and cyclic antagonists of the receptor for the complement factor C5a. J. Med. Chem. 42: 1965-1974
20. Mollnes, T. E., O.-L. Brekke, M. Fung, H. Fure, D. Christiansen, G. Bergseth, V. Videm, K. T. Lappegård, J. Köhl, and J. D. Lambris. 2002. Essential role of the C5a receptor in E coli-induced oxidative burst and phagocytosis revealed by a novel lepirudin-based human whole blood model of inflammation. Blood 100: 1869-1877
21. Gräbner, R., U. Till, and R. Heller. 2000. Flow cytometric determination of E-selectin, vascular cell adhesion molecule-1, and intercellular cell adhesion molecule-1 in formaldehyde-fixed endothelial cell monolayers. Cytometry 40: 238-244
22. Haskard, D. O. 2008. Endothelial Activation in Inflammation: Lessons Learned from E-Selectin. In Vascular Complications in Human Disease: Mechanisms and Consequences. D. Abraham, M. Dashwood, C. Handler, and G. Coghlan, eds. Springer, London, p. 77-93
23. Bexborn, F., A. E. Engberg, K. Sandholm, T. E. Mollnes, J. Hong, and K. Nilsson Ekdahl. 2009. Hirudin versus heparin for use in whole blood in vitro biocompatibility models. J. Biomed. Mater. Res. A 89: 951-959
24. O'Donnell, J., B. Mille-Baker, and M. Laffan. 2000. Human umbilical vein endothelial cells differ from other endothelial cells in failing to express ABO blood group antigens. J. Vasc. Res. 37: 540-547
25. Lloyd-Jones, K. L., M. M. Kelly, and P. Kubes. 2008. Varying importance of soluble and membrane CD14 in endothelial detection of lipopolysaccharide. J. Immunol. 181: 1446-1453
26. Andonegui, G., H. Zhou, D. Bullard, M. M. Kelly, S. C. Mullaly, B. McDonald, E. M. Long, S. M. Robbins, and P. Kubes. 2009. Mice that exclusively express TLR4 on endothelial cells can efficiently clear a lethal systemic Gram-negative bacterial infection. J. Clin. Invest. 119: 1921-1930
27. Nooteboom, A., C. J. van der Linden, and T. Hendriks. 2004. Modulation of adhesion molecule expression on endothelial cells after induction by lipopolysaccharide-stimulated whole blood. Scand. J. Immunol. 59: 440-448
28. Schildberger, A., E. Rossmanith, V. Weber, and D. Falkenhagen. 2010. Monitoring of endothelial cell activation in experimental sepsis with a two-step cell culture model. Innate Immun. 16: 278-287
29. Lu, Z., Y. Li, J. Jin, X. Zhang, M. F. Lopes-Virella, and Y. Huang. 2012. Toll-like receptor 4 activation in microvascular endothelial cells triggers a robust inflammatory response and cross talk with mononuclear cells via interleukin-6. Arterioscler. Thromb. Vasc. Biol. 32: 1696-1706
30. Thorgersen, E. B., B. C. Hellerud, E. W. Nielsen, A. Barratt-Due, H. Fure, J. K. Lindstad, A. Pharo, E. Fosse, T. I. Tønnessen, H. T. Johansen, et al. 2010. CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs. FASEB J. 24: 712-722
31. Hellerud, B. C., A. Aase, T. K. Herstad, L. M. Naess, L. H. Kristiansen, A.-M. S. Trøseid M. Harboe, K. T. Lappegård, P. Brandtzaeg, E. A. Høiby, and T. E. Mollnes. 2010. Critical roles of complement and antibodies in host defense mechanisms against Neisseria meningitidis as revealed by human complement genetic deficiencies. Infect. Immun. 78: 802-809
32. Thorgersen, E. B., A. Pharo, K. Haverson, A. K. Axelsen, P. Gaustad, G. J. Kotwal, G. Sfyroera, and T. E. Mollnes. 2009. Inhibition of complement and CD14 attenuates the Escherichia coli-induced inflammatory response in porcine whole blood. Infect. Immun. 77: 725-732
33. Brekke, O.-L., D. Christiansen, H. Fure, M. Fung, and T. E. Mollnes. 2007. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood. J. Leukoc. Biol. 81: 1404-1413
34. Sprong, T., A.-S. W. Møller, A. Bjerre, E. Wedege, P. Kierulf, J. W. M. van der Meer, P. Brandtzaeg, M. van Deuren, and T. E. Mollnes. 2004. Complement activation and complement-dependent inflammation by Neisseria meningitidis are independent of lipopolysaccharide. Infect. Immun. 72: 3344-3349
35. Egge, K. H., A. Barratt-Due, S. Nymo, J. K. Lindstad, A. Pharo, C. Lau, T. Espevik, E. B. Thorgersen, and T. E. Mollnes. 2015. The anti-inflammatory effect of combined complement and CD14 inhibition is preserved during escalating bacterial load. Clin. Exp. Immunol. 181: 457-467
36. Pugin, J., R. J. Ulevitch, and P. S. Tobias. 1995. Tumor necrosis factor-α and interleukin-1b mediate human endothelial cell activation in blood at low endotoxin concentrations. J. Inflamm. 45: 49-55
37. Nooteboom, A., R. P. Bleichrodt, and T. Hendriks. 2006. Modulation of endothelial monolayer permeability induced by plasma obtained from lipopolysaccharide-stimulated whole blood. Clin. Exp. Immunol. 144: 362-369
38. Nooteboom, A., C. J. van der Linden, and T. Hendriks. 2005. Whole bloodmediated endothelial permeability and adhesion molecule expression: a model study into the effects of bacteria and antibiotics. J. Antimicrob. Chemother. 55: 150-156
39. Schildberger, A., T. Buchacher, V. Weber, and D. Falkenhagen. 2011. Adsorptive modulation of inflammatory mediators dampens endothelial cell activation. Blood Purif. 32: 286-295
40. Foreman, K. E., M. M. Glovsky, R. L. Warner, S. J. Horvath, and P. A. Ward. 1996. Comparative effect of C3a and C5a on adhesion molecule expression on neutrophils and endothelial cells. Inflammation 20: 1-9
41. Kilgore, K. S., J. P. Shen, B. F. Miller, P. A. Ward, and J. S. Warren. 1995. Enhancement by the complement membrane attack complex of tumor necrosis factor-α-induced endothelial cell expression of E-selectin and ICAM-1. J. Immunol. 155: 1434-1441
42. Foreman, K. E., A. A. Vaporciyan, B. K. Bonish, M. L. Jones, K. J. Johnson, M. M. Glovsky, S. M. Eddy, and P. A. Ward. 1994. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94: 1147-1155
43. Harboe, M., G. Ulvund, L. Vien, M. Fung, and T. E. Mollnes. 2004. The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation. Clin. Exp. Immunol. 138: 439-446